Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2018

Aug 27, 2018

32845_dirs_2018-08-27_8f2c5e75-adc4-469a-8ea9-cfc586181564.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-08-23

Reporting Person: Sutton Gregg S (VP of Research and Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-08-23 Common Stock M 10544 $19.42 Acquired 19853 Direct
2018-08-23 Common Stock M 4280 $23.95 Acquired 24133 Direct
2018-08-23 Common Stock S 14204 $74.1079 Disposed 9929 Direct
2018-08-23 Common Stock S 620 $74.9419 Disposed 9309 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-08-23 Employee Stock Option (right to buy) $19.42 M 10544 Disposed 2023-02-16 Common Stock (10544) Direct
2018-08-23 Employee Stock Option (right to buy) $23.95 M 4280 Disposed 2023-11-30 Common Stock (4280) Direct

Footnotes

F1: Includes 497 shares acquired through the Employee Stock Purchase Plan for the phase ending in February 2018.

F2: Reflects the weighted average price of 14,204 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $73.80 to $74.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 620 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $74.825 to $75.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: The award vests in four equal installments on each of the first four anniversaries of the February 16, 2016 grant date.

F5: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.